Results 1 to 10 of about 55,621 (311)

New aspects in the management of pneumonia [PDF]

open access: yesCritical Care, 2016
Despite improvements in the management of community-acquired pneumonia (CAP), morbidity and mortality are still high, especially in patients with more severe disease.
Elena Prina   +2 more
doaj   +5 more sources

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers

open access: yesFrontiers in Pharmacology, 2021
Patients in septic shock with low IgG and IgM serum concentrations have higher mortality rates compared to those with normal immunoglobulin levels and, therefore, there is a rational explanation to administer intravenous IgM-enriched immunoglobulins to ...
Giuliana Scarpati   +7 more
doaj   +1 more source

Intravenous Immunoglobulin

open access: yesIndian Journal of Dermatology, 2021
Background: Many a times while treating dermatoses conventional therapies are either contraindicated or not effective. Intravenous immunoglobulin (IVIG) is a good alternative available to tide over crises. Method: Over the last 15 years of my practice I have used IVIg in various ...
Sanjeev S Vaishampayan   +5 more
openaire   +3 more sources

LIVEdoid vasculopathy – benefit of intravenous immunoglobulin in a refractory case [PDF]

open access: yesRomanian Journal of Rheumatology, 2021
Livedoid vasculopathy is a rare vascular disease which typically manifests as recurrent ulcerative lesions on the lower extremities. It is classified as a vasculopathy, not a true vasculitis, and defined as a vasooclusive syndrome, caused by non ...
Stefan Cristian Dinescu   +7 more
doaj   +1 more source

Prurigo nodularis responding to intravenous immunoglobulins

open access: yesPrzegląd Dermatologiczny, 2022
Prurigo nodularis is a chronic skin disease, especially seen in middle-aged women adults. It is characterized by symmetric, pruritic hyperkeratotic nodules and papules on the extensor surfaces [1].
Koray Durmaz   +3 more
doaj   +1 more source

Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report

open access: yesCase Reports in Women's Health, 2022
Gestational alloimmune liver disease is a rare complication associated with reactive maternal immunoglobulins resulting in neonatal liver pathology. The mainstay treatment for prevention in future pregnancies is intravenous immunoglobulins.
Minhazur Sarker   +2 more
doaj   +1 more source

Immune-mediated necrotizing myopathy which showed deposition of C5b-9 in the necrotic muscle fibers and was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and intravenous immunoglobulins

open access: yesImmunological Medicine, 2022
Currently, no standard treatment strategy has been established for immune-mediated necrotizing myopathy (IMNM). Here we present a case of IMNM which was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and ...
Tatsuya Shimada   +7 more
doaj   +1 more source

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement [PDF]

open access: yes, 2014
Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients
AA Bousfiha   +55 more
core   +6 more sources

Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses

open access: yesActa Dermato-Venereologica, 2020
Intravenous immunoglobulins are an effective and well-tolerated treatment option for immune dermatological diseases. However, they are primarily used to treat diseases with a severe course and are mostly used off-label.
Roberta Scarpone   +3 more
doaj   +1 more source

Comparison of serum immunoglobulin G half-life in dairy calves fed colostrum, colostrum replacer or administered with intravenous bovine plasma. [PDF]

open access: yes, 2014
In calves, passive immunity of immunoglobulins can be acquired through ingestion of colostrum or colostrum replacers. Plasma can been used to supplement immunoglobulins in healthy or sick calves.
Chigerwe, Munashe   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy